Meridian Clinical Research

Hastings, Nebraska 68901

0 studies enrolling now · 10 studies all time

What they study most

Gastro-Intestinal Tolerance, Group B Streptococcus Infections, Human Papillomavirus, Influenza, Migraine, Pneumococcal Disease, Pneumococcal Vaccines, Respiratory Syncytial Virus (RSV), Respiratory Tract Infection, SARS-CoV-2

Studies at this site

• A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age — Completed
• Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants — Completed
• Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants — Completed
• A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. — Completed
• Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults — Completed
• AMG 334 20160172 Pediatric Migraine PK Study. — Completed
• Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Formula Tolerance of Term Infants — Completed
• Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months — Status unconfirmed